Insider Buying Signals Confidence at Concentrix and Altimmun (CNXC, ALT)

Insider Buying Signals Confidence at Concentrix and Altimmune

Apr 10, 2026 17:39 UTC

CNXC, ALT

Short term

Recent regulatory filings reveal that key insiders at Concentrix Corp (CNXC) and Altimmune (ALT) have increased their ownership stakes, suggesting a bullish outlook from within the organizations. Andre S. Valentine, Chief Financial Officer of Concentrix Corp, acquired 2,500 shares on Thursday. The transaction was executed at a price of $27.95 per share, totaling an investment of $69,869. While the stock saw a brief intraday peak of $29.94, it closed Friday down approximately 1%. Similarly, Altimmune saw buying activity from John Gill, who purchased 9,200 shares on Monday at $3.41 per share, representing a total outlay of $31,350. This follows a previous acquisition by Gill within the last year, where he purchased $51,250 worth of shares at a higher price point of $4.10. Despite these insider purchases, both equities faced headwinds on Friday, with Altimmune trading down roughly 4.2%. However, open-market buying by C-suite executives is often viewed by traders as a signal that the current market price may be undervalued relative to internal projections.

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Insider Buying Signals Confidence at Concentrix and Altimmune

Sign up free to read the full analysis

Related Articles

Roche and Sarepta Launch Phase 3 Trial to Secure EU Approval for Elevidys

Anthropic Launches Claude Opus 4.7 with Enhanced Safety Guardrails

Planet Labs Shares Surge Despite Insider Stock Sale

Ex-Div Reminder for Zoetis (ZTS)

Stay Ahead of the Markets

Wait — Don't Miss Out!